Comparative steady-state pharmacokinetic evaluation of immediate-release topiramate and USL255, a once-daily extended-release topiramate formulation

Assessing bioequivalence of generic antiepilepsy drugs

(2011) Gregory L. Krauss et al.   ANNALS OF NEUROLOGY

Comparative pharmacokinetic analysis of USL255, a new once-daily extended-release formulation of topiramate

(2011) Lawrence J. Lambrecht et al.   EPILEPSIA

Challenges and opportunities in establishing scientific and regulatory standards for determining therapeutic equivalence of modified-release products: Workshop summary report

(2010) Mei-Ling Chen et al.   CLINICAL THERAPEUTICS

Pharmacokinetic-pharmacodynamic assessment of topiramate dosing regimens for children with epilepsy 2 to

(2010) Ihab G. Girgis et al.   EPILEPSIA

Extended-release lamotrigine in the treatment of patients with epilepsy

(2010) Tanvir U Syed et al.   EXPERT OPINION ON PHARMACOTHERAPY

Evaluation of Methods for Estimating Time to Steady State with Examples from Phase 1 Studies

(2008) Lata Maganti et al.   AAPS Journal

The Operational Multiple Dosing Half-life: A Key to Defining Drug Accumulation in Patients and to Designing Extended Release Dosage Forms

(2008) Selma Sahin et al.   PHARMACEUTICAL RESEARCH